Alex Zhavoronkov
Founder, CEO & CBO Insilico Medicine
Seminars
Thursday 29th January 2026
Pharmaceutical Superintelligence (PSI): Transforming Drug Discovery and the Future of Aging Research
1:30 pm
- End-to-End Drug Discovery: PSI unifies generative design, predictive modeling, and automated experimentation to accelerate the full drug discovery cycle, from targets to therapies
- Data-Driven Insights: By integrating omics, clinical, and real-world datasets, PSI uncovers mechanisms of aging and prioritizes interventions that extend healthspan
- Faster Translation: PSI compresses timelines and reduces costs by enabling rapid validation and testing of geroprotectors and longevity drugs
- Collaborative Research Partner: Designed as more than a tool, PSI empowers scientists to simulate interventions, explore hypotheses, and drive breakthroughs in aging therapeutics
